PFE: Pfizer Corp Cash Money per Share

Symbol and logo of brand Pfizer Corp (PFE)

Following a large-scale oncology acquisition and cost optimization, the cash per share reflects the current liquidity of Pfizer Inc. (PFE). The value 2.49 captures the current magnitude of this indicator. While Pfizer Inc. (PFE) previously expanded its influence through biotech mergers, it now supports innovation via global research alliances and the funding of academic projects to accelerate vaccine development.

PFE Pfizer Inc: Cash Funds per Share in the range 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for Pfizer Inc (PFE)

- market value and analyst target forecast:
- market capitalization information:
- cash and cash flow data:
Comprehensive company analysis:Pfizer Corporation PFE
Flagship merchandise of Pfizer

Searching for fundamentally resilient assets requires a liquidity analysis via cash per share, which determines the financial margin of safety and risk appetite. For Pfizer Inc. (PFE), this metric reflects the holding's ability to fund the development of new drugs and protect patents; therefore, analyzing the free cash flow per share chart allows for an assessment of the balance between operational stability and investment activity.